Thermo Fisher Scientific TMO Life Sciences Solutions — Selling, general and administrative expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Thermo Fisher Scientific's life sciences solutions — selling, general and administrative expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Thermo Fisher Scientific's life sciences solutions — selling, general and administrative expenses?
- Thermo Fisher Scientific (TMO) reported life sciences solutions — selling, general and administrative expenses of $496M in Q1 2026.
- How has Thermo Fisher Scientific's life sciences solutions — selling, general and administrative expenses changed year-over-year?
- Thermo Fisher Scientific's life sciences solutions — selling, general and administrative expenses increased by 6.0% year-over-year, from $468M to $496M.
- What does life sciences solutions — selling, general and administrative expenses mean?
- The operating costs incurred by the Life Sciences Solutions segment that are not directly tied to production, including sales commissions, marketing, legal, and administrative overhead. It reflects the cost of supporting the segment's commercial infrastructure.